Resources

Publications

Latest
  1. Speranza ED, Jeronimo M, Colombo M. Initial assessment of multi-compound antineoplastic drug surface contamination in Argentinean healthcare centers: Insights into occupational exposures in South America. Journal of Oncology Pharmacy Practice. 2023.
Older
  1. Astrakianakis G, Jeronimo M, Griffiths A, Colombo M, Kramer D, Demers PA, Hon CY. The application of novel field measurement and field evaluation protocols for assessing health care workers’ exposure risk to antineoplastic drugs. Journal of Occupational and Environmental Hygiene. 2020; 7(9).
  2. Davies H, Arnold S, Jeronimo M, Astrakianakis G, Chambers C. Surface Sampling for Chemotherapy Drugs: Lessons Learned from the Surveillance for Anti-cancer Drugs Exposure Study. AIHA Synergist. 2020 July; 17(9): 373–382.
  3. Colombo M, Jeronimo M, Astrakianakis G, Apte C, Hon CY. Wipe Sampling Method and Evaluation of Environmental Variables for Assessing Surfaces Contamination of 10 Antineoplastic Drugs by Liquid Chromatography/Tandem Mass Spectrometry. Annals of Work Exposures and Health. 2017 August; 61(8):1003-1014.
  4. Hall AL, Demers PA, Astrakianakis G, Ge C, Peters CE. Estimating National-Level Exposure to Antineoplastic Agents in the Workplace: CAREX Canada Findings and Future Research Needs. Annals of Work Exposures and Health. 2017 June; 61(6):656-658.
  5. Jeronimo M, Colombo M, Astrakianakis G, Hon CY. A Surface Wipe Sampling and LC-MS/MS Method for the Simultaneous Detection of Six Antineoplastic Drugs Commonly Handled by Healthcare Workers. Anal Bioanal Chem. 2015 September; 407(23):7083-7092.

Conference Presentations

Latest
  1. 2020 American Industrial Hygiene Association (AIHA) Georgia Local Section Conference, “Lessons from the Surveillance for Anti-Cancer drugs Exposure Study (SurFACES)”, February 2020. (S. Arnold)

Older
  1. 2019 University of Minnesota Research Day Lightning Talk. “Antineoplastic Drugs: An Occupational Hazard for Healthcare Workers. (H. Kaup, S. Arnold)
  2. 2019 American Industrial Hygiene Association (AIHA) Conference and Exposition. “Lessons Learned in the Field” Minneapolis, Minnesota, May 2019.
  3. 2019 American Industrial Hygiene Association (AIHA) Conference and Exposition. “Lessons Learned from the Lab” Minneapolis, Minnesota, May 2019.
  4. 2019 American Industrial Hygiene Association (AIHA) Conference and Exposition. “Lessons from the Clinic and Pharmacy” Minneapolis, Minnesota, May 2019.
  5. 2019 American Industrial Hygiene Association (AIHA) Conference and Exposition. Poster: Establishing Antineoplastic Drug Surveillance in Healthcare Settings (H. Kaup)
  6. 2019 Hematology Oncology Association Conference. Poster: Establishing an Antineoplastic Surveillance Program In Preparation For USP Chapter <800> (Emily Schroeder)

Seminars

Latest
  1. Spring, 2020 OEH Seminar Series. “Advancing Surveillance Protocols for Antineoplastic Drug Exposures in Health Care Settings” (H. Davies)

Older
  1. Fall, 2018 OEH Seminar Series. “Surveillance for Occupational Exposures to Antineoplastic Drugs in Hospital Settings in Alberta and Minnesota” (H. Davies)